| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.35 | 0.2 |